Veracyte (VCYT) Stock Chart & Stock Price History $27.08 -0.44 (-1.60%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$27.38 +0.30 (+1.11%) As of 07/11/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Veracyte Stock Price Performance The Veracyte (VCYT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 19.03%, with a year-to-date return of -31.62%. In the past month, the stock has increased 1.46%, reflecting recent market activity. As of the latest close, Veracyte traded at $27.08 with a market cap of $2.12 billion and volume of 1.07 million shares. Five years ago, the stock traded at $29.54, representing a 8.33% decrease over that period. At the time, it had a market cap of $1.48 billion and a volume of 315,000 shares. Receive VCYT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Veracyte and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.81%1 Month Performance+1.46%3 Month Performance-14.84%Year-To-Date Performance-31.62%1 Year Performance+19.03%5 Year Performance-8.33% VCYT Stock Chart for Saturday, July, 12, 2025 VCYT Chart by TradingView Veracyte Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$27.52$27.08-1.60%$27.75$26.791.07 million shs$2.12 billion07/10/2025$27.08$27.52+1.62%$27.91$26.83936,247 shs$2.16 billion07/09/2025$26.58$27.08+1.88%$27.38$26.34823,071 shs$2.08 billion07/08/2025$26.34$26.58+0.91%$26.78$26.18739,796 shs$2.08 billion07/07/2025$27.51$26.34-4.25%$27.75$26.28691,394 shs$2.06 billion07/04/2025$27.51$27.51$27.95$27.26445,469 shs$2.15 billion07/03/2025$27.58$27.51-0.25%$27.95$27.26445,469 shs$2.15 billion07/02/2025$27.32$27.58+0.95%$27.77$27.021.09 million shs$2.16 billion07/01/2025$27.03$27.32+1.07%$27.74$26.591.07 million shs$2.14 billion06/30/2025$27.38$27.03-1.28%$27.70$26.89701,420 shs$2.12 billion Get the Latest News and Ratings for VCYT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Veracyte and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$26.81$27.38+2.13%$27.64$26.523.60 million shs$2.14 billion06/26/2025$26.45$26.81+1.36%$26.83$26.01919,724 shs$2.10 billion06/25/2025$26.88$26.45-1.60%$26.94$26.28815,293 shs$2.07 billion06/24/2025$26.71$26.88+0.64%$27.21$26.57534,867 shs$2.11 billion06/23/2025$26.39$26.71+1.21%$26.73$25.86608,520 shs$2.09 billion06/20/2025$26.82$26.39-1.60%$27.28$26.151.68 million shs$2.07 billion06/19/2025$26.82$26.82$27.11$25.99687,335 shs$2.10 billion06/18/2025$26.76$26.82+0.22%$27.11$25.99687,335 shs$2.10 billion06/17/2025$26.64$26.76+0.45%$26.84$25.91745,858 shs$2.10 billion06/16/2025$26.44$26.64+0.76%$26.92$25.85634,209 shs$2.09 billion06/13/2025$26.69$26.44-0.94%$27.01$26.20953,596 shs$2.07 billion06/12/2025$27.93$26.69-4.44%$27.86$26.52774,320 shs$2.09 billion06/11/2025$27.88$27.93+0.18%$28.43$27.521.22 million shs$2.19 billion Related Companies Adaptive Biotechnologies Stock Chart Beam Therapeutics Stock Chart Guardant Health Stock Chart Twist Bioscience Stock Chart 10x Genomics Stock Chart Option Care Health Stock Chart RadNet Stock Chart BrightSpring Health Services Stock Chart Sotera Health Stock Chart Surgery Partners Stock Chart Receive VCYT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Veracyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VCYT) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
